Results for tag: "Genetic Drug"

The Genetic Drug market is a subset of the Pharmaceuticals industry that focuses on the development and commercialization of drugs that are tailored to the genetic makeup of individual patients. These drugs are designed to target specific genetic mutations that are associated with certain diseases, and are often used to treat rare and complex conditions. Genetic drugs are typically developed through the use of gene therapy, which involves the insertion of a gene into a patient’s cells to replace a defective gene or to supplement a missing gene. The Genetic Drug market is expected to experience strong growth in the coming years, driven by advances in gene therapy and the increasing prevalence of rare and complex diseases. Additionally, the increasing availability of genomic data and the development of new technologies to analyze this data are expected to further drive the growth of the market. Some of the major companies in the Genetic Drug market include Novartis, Pfizer, Merck, Sanofi, and Amgen. Show Less Read more